Loading clinical trials...
Loading clinical trials...
An Open-lable, Single Arm, Single Center, Phase 2 Study of PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell
Conditions
Interventions
SHR1210
Start Date
October 20, 2018
Primary Completion Date
March 30, 2020
Completion Date
June 30, 2021
Last Updated
October 9, 2018
NCT06406556
NCT01787409
NCT03493451
NCT04509466
NCT02168140
NCT01769222
Lead Sponsor
Peking University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions